[The management of asymptomatic bacteriuria in different patient population]
1Département de médecine, Hôpitaux neuchâtelois, Site Pourtalès, 2000 Neuchâtel. Marie-Laure.Ivanov@ne.ch
Insights
Screening for asymptomatic bacteriuria (AB) is recommended for pregnant women and before uro-gynecologic surgery. Treatment is generally not advised for other populations due to potential negative outcomes and antibiotic resistance.
Area of Science:
- Urology
- Infectious Diseases
- Public Health
Context:
- Asymptomatic bacteriuria (AB) is a common condition with varying management guidelines.
- Clinical practice often deviates from established recommendations for AB treatment.
- Understanding appropriate screening and treatment is crucial for patient outcomes.
Purpose:
- To provide updated guidance on screening and treatment protocols for asymptomatic bacteriuria (AB).
- To clarify management strategies for AB across diverse patient demographics.
- To highlight discrepancies between current clinical practice and evidence-based recommendations.
Summary:
- Systematic screening for AB is recommended in pregnant women due to complication risks and before uro-gynecologic procedures.
- Management of AB in immunosuppressed or transplanted patients remains controversial.
- Treatment of AB in general populations is not advised and may lead to adverse effects, including the selection of resistant organisms.
Impact:
- Aims to improve patient care by aligning clinical practice with evidence-based AB management.
- Reducing unnecessary antibiotic use for AB can mitigate the development of antimicrobial resistance.
- Informing healthcare providers about optimal AB screening and treatment can prevent complications and improve outcomes.
Abstract:
Who should be screened for asymptomatic bacteriuria (AB) and who should be treated? This review updates some aspects of the management of AB in different patient populations. A systematic screening for AB is recommended for pregnant women because of a significant risk of complications. In these cases as well as before any uro-gynecologic surgical procedure treatment of AB is strongly recommended. The management of AB in immunosuppressed or transplanted patients is more controversial. In other populations treating AB is not recommended and the outcome seems to be worse in case of treatment due to possible side effects and selection of resistant organisms. Recent studies have shown a considerable gap between clinical practice and recommendations.
Related Concept Videos
Urinary Tract Infection IV: Nursing Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection I: Introduction
Microbiota of the Urogenital Tract

